We are live on
!
Find out more
N
Natixis Portfolio holdings
AUM
$28B
1-Year Est. Return
26.79%
Natixis is a global financial services business line of Groupe BPCE, offering a range of services including corporate and investment banking, asset management, insurance, and wealth management, with a focus on green and sustainable finance.
This Fund
S&P 500
This Quarter
Est. Return
-2.18%
1 Year Est. Return
+26.79%
3 Year Est. Return
+97.72%
5 Year Est. Return
+108.83%
10 Year Est. Return
+452.99%
AUM
$13.1B
AUM Growth
+$754M
(+6.1%)
Cap. Flow
+$1.16B
Cap. Flow
% of AUM
8.89%
Top 10 Holdings %
Top 10 Hldgs %
38.02%
Holding
1,188
New
182
Increased
340
Reduced
340
Closed
221
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$379M |
| 2 |
NVIDIA
NVDA
|
+$323M |
| 3 |
Amazon
AMZN
|
+$133M |
| 4 |
UnitedHealth
UNH
|
+$97.5M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$86.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$89.2M |
| 2 |
ExxonMobil
XOM
|
+$83.6M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$83.1M |
| 4 |
CVS Health
CVS
|
+$82.2M |
| 5 |
Eli Lilly
LLY
|
+$66.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.23% |
| 2 | Healthcare | 11.42% |
| 3 | Energy | 7.9% |
| 4 | Consumer Discretionary | 6.67% |
| 5 | Financials | 5.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HAPN
751
Happen Inc
HAPN
$2.08B
| $121K | ﹤0.01% |
19,861
-6,469
| -25% | -$50.3K |
|
752
Republic Services
RSG
$66.7B
| $120K | ﹤0.01% |
+842
| New | +$125K |
|
|
NVEE
753
DELISTED
NV5 Global
NVEE
| $118K | ﹤0.01% |
4,896
-20
| -0.4% | -$516 |
|
754
Criteo
CRTO
$1.03B
| $116K | ﹤0.01% |
3,959
| – | – |
|
755
Vail Resorts
MTN
$5.19B
| $112K | ﹤0.01% |
+504
| New | +$120K |
|
|
GTY
756
Getty Realty Corp
GTY
$2.1B
| $111K | ﹤0.01% |
+4,000
| New | +$124K |
|
757
BioNTech
BNTX
$22.6B
| $110K | ﹤0.01% |
1,013
-5,850
| -85% | -$647K |
|
758
Burlington
BURL
$22B
| $110K | ﹤0.01% |
811
+639
| +372% | +$102K |
|
759
iShares MSCI Emerging Markets ETF
EEM
$28B
| $110K | ﹤0.01% |
2,890
| – | – |
|
760
Tradeweb Markets
TW
$21.3B
| $109K | ﹤0.01% |
1,361
+1,066
| +361% | +$85K |
|
761
Lemonade
LMND
$4.62B
| $109K | ﹤0.01% |
+9,391
| New | +$151K |
|
762
WisdomTree Japan Hedged Equity Fund
DXJ
$7.23B
| $108K | ﹤0.01% |
1,221
| – | – |
|
763
Aramark
ARMK
$15B
| $107K | ﹤0.01% |
4,284
-521,494
| -99% | -$14.6M |
|
764
Dycom Industries
DY
$12.9B
| $105K | ﹤0.01% |
1,183
-5
| -0.4% | -$499 |
|
|
SWAV
765
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $104K | ﹤0.01% |
+524
| New | +$124K |
|
|
SUM
766
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $104K | ﹤0.01% |
3,338
-15
| -0.4% | -$534 |
|
767
Intellia Therapeutics
NTLA
$1.5B
| $101K | ﹤0.01% |
+3,201
| New | +$124K |
|
768
American Financial Group
AFG
$11.9B
| $101K | ﹤0.01% |
904
+712
| +371% | +$82.2K |
|
769
Lear
LEA
$7.19B
| $99K | ﹤0.01% |
738
+580
| +367% | +$83.9K |
|
770
Baker Hughes
BKR
$56.8B
| $95.2K | ﹤0.01% |
2,694
-116,552
| -98% | -$4.13M |
|
771
Qfin Holdings
QFIN
$1.61B
| $95K | ﹤0.01% |
6,183
+3,803
| +160% | +$64.9K |
|
|
IFLN
772
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$305M
| $94.4K | ﹤0.01% |
5,528
+68
| +1% | +$1.18K |
|
|
DQ
773
Daqo New Energy
DQ
$790M
| $92.1K | ﹤0.01% |
3,041
-461
| -13% | -$16.4K |
|
774
Cognex
CGNX
$10.3B
| $91.5K | ﹤0.01% |
2,156
+1,697
| +370% | +$83.4K |
|
775
Mueller Water Products
MWA
$3.92B
| $90.9K | ﹤0.01% |
7,165
-32
| -0.4% | -$461 |
|
Similar funds
TWC
FDCDDQ
PCH
NA
Natixis's Q3 2023 Portfolio in Review
As of Q3 2023, Natixis held 1,188 positions worth $13.1B, up 6.1% from $12.3B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Natixis deployed $1.16B of net new capital in Q3 2023, opening 182 new positions and adding to 340 existing holdings. Its largest new stake was Oneok: 965,015 shares worth $61.2M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 21% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $89.2M trimmed.
- Natixis's largest Q3 2023 buy was Oneok: 965,015 shares worth $61.2M.
- Natixis added most to Apple in Q3 2023, an estimated $379M increase.
- Natixis's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $89.2M.
- Natixis fully exited Bristol-Myers Squibb in Q3 2023, selling an estimated $83.1M.
- Natixis's ten largest holdings make up 38% of its $13.1B portfolio in Q3 2023.
- Natixis opened 182 new positions and closed 221 in Q3 2023.
- Natixis's portfolio value rose 6.1% quarter-over-quarter to $13.1B.
Based on Natixis's 13F filing for Q3 2023, filed 14 Nov 2023.